STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $400,000 | -66.5% | 196,365 | -51.2% | 0.00% | – |
| Q2 2021 | $1,195,000 | +930.2% | 402,297 | +857.9% | 0.00% | – |
| Q1 2021 | $116,000 | +107.1% | 41,998 | +82.4% | 0.00% | – |
| Q4 2020 | $56,000 | -17.6% | 23,023 | -28.7% | 0.00% | – |
| Q3 2020 | $68,000 | -43.8% | 32,303 | +0.9% | 0.00% | – |
| Q2 2020 | $121,000 | +157.4% | 32,009 | +29.2% | 0.00% | – |
| Q1 2020 | $47,000 | -33.8% | 24,766 | -27.7% | 0.00% | – |
| Q4 2019 | $71,000 | +1.4% | 34,240 | +16.4% | 0.00% | – |
| Q3 2019 | $70,000 | -20.5% | 29,426 | +4.9% | 0.00% | – |
| Q2 2019 | $88,000 | -81.7% | 28,039 | -70.9% | 0.00% | – |
| Q1 2019 | $480,000 | +451.7% | 96,342 | +398.2% | 0.00% | – |
| Q4 2018 | $87,000 | -85.3% | 19,338 | -84.1% | 0.00% | – |
| Q3 2018 | $590,000 | -74.7% | 121,587 | -68.7% | 0.00% | -100.0% |
| Q2 2018 | $2,330,000 | +756.6% | 388,395 | +1163.0% | 0.00% | – |
| Q1 2018 | $272,000 | 0.0% | 30,752 | -18.1% | 0.00% | – |
| Q4 2017 | $272,000 | – | 37,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
| RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
| NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
| Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
| Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
| Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
| Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
| Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,114 | $24,000 | 0.00% |